|
1
|
Funk GF, Karnell LH, Robinson RA, et al:
Presentation, treatment, and outcome of oral cavity cancer: A
National Cancer Data Base report. Head Neck. 24:165–180. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kirita T, Ohgi K, Shimooka H, Yamanaka Y,
Tatebayashi S, Yamamoto K, Mishima K and Sugimura M: Preoperative
concurrent chemoradiotherapy plus radical surgery for advanced
squamous cell carcinoma of the oral cavity: An analysis of
long-term results. Oral Oncol. 35:597–606. 1999. View Article : Google Scholar
|
|
4
|
Freier K, Engel M, Lindel K,
Flechtenmacher C, Mühling J, Hassfeld S and Hofele C: Neoadjuvant
concurrent radiochemotherapy followed by surgery in advanced oral
squamous cell carcinoma (OSCC): A retrospective analysis of 207
patients. Oral Oncol. 44:116–123. 2008. View Article : Google Scholar
|
|
5
|
Mohr C, Bohndorf W, Carstens J, et al:
Preoperative radiochemotherapy and radical surgery in comparison
with radical surgery alone. Int J Oral Maxillofac Surg. 23:140–148.
1994.PubMed/NCBI
|
|
6
|
Klug C, Berzaczy D, Voracek M and Millesi
W: Preoperative chemoradiotherapy in the management of oral cancer:
A review. J Craniomaxillofac Surg. 36:75–88. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kirita T, Yamanaka Y, Imai Y, Yamakawa N,
Aoki K, Nakagawa Y, Yagyuu T and Hasegawa M: Preoperative
concurrent chemoradiotherapy for stages II–IV oral squamous cell
carcinoma: A retrospective analysis and the future possibility of
this treatment strategy. Int J Oral Maxillofac Surg. 41:421–428.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kawano S, Zheng Y, Oobu K, Matsubara R,
Goto Y, Chikui T, Yoshitake T, Kiyoshima K, Jinno T, Maruse Y,
Mitate E, Kitmura R, Tanaka H, Toyoshima T, Sugiura T and Nakamura
S: Clinicopathological evaluation of preoperative chemoradiotherapy
with S-1 for locally advanced oral squamous cell carcinoma. Oncol
Lett (In press);
|
|
9
|
Matsubara R, Kawano S, Kiyosue T, Goto Y,
Hirano M, Jinno T, Toyoshima T, Kitamura R, Oobu K and Nakamura S:
Increased ΔNp63 expression is predictive of malignant
transformation in oral epithelial dysplasia and poor prognosis in
oral squamous cell carcinoma. Int J Oncol. 39:1391–1399.
2011.PubMed/NCBI
|
|
10
|
Kiyosue T, Kawano S, Matsubara R, Goto Y,
Hirano M, Jinno T, Toyoshima T, Kitamura R, Oobu K and Nakamura S:
Immunohistochemical location of the p75 neurotrophin receptor
(p75NTR) in oral leukoplakia and oral squamous cell carcinoma. Int
J Clin Oncol. 18:154–163. 2013. View Article : Google Scholar
|
|
11
|
Goto Y, Kawano S, Matsubara R, et al:
Possible involvement of ΔNp63 downregulation in the invasion and
metastasis of oral squamous cell carcinoma via induction of a
mesenchymal phenotype. Clin Exp Metastasis. 31:293–306. 2014.
View Article : Google Scholar
|
|
12
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kishimoto T: Interleukin-6: From basic
science to medicine - 40 years in immunology. Annu Rev Immunol.
23:1–21. 2005. View Article : Google Scholar
|
|
14
|
Kurzrock R, Redman J, Cabanillas F, Jones
D, Rothberg J and Talpaz M: Serum interleukin 6 levels are elevated
in lymphoma patients and correlate with survival in advanced
Hodgkin’s disease and with B symptoms. Cancer Res. 53:2118–2122.
1993.PubMed/NCBI
|
|
15
|
Schafer ZT and Brugge JS: IL-6 involvement
in epithelial cancers. J Clin Invest. 117:3660–3663. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin MT, Lin BR, Chang CC, Chu CY, Su HJ,
Chen ST, Jeng YM and Kuo ML: IL-6 induces AGS gastric cancer cell
invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Int J Cancer. 120:2600–2608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wong VW, Yu J, Cheng AS, Wong GL, Chan HY,
Chu ES, Ng EK, Chan FK, Sung JJ and Chan HL: High serum
interleukin-6 level predicts future hepatocellular carcinoma
development in patients with chronic hepatitis B. Int J Cancer.
124:2766–2770. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen CC, Chen WC, Lu CH, Wang WH, Lin PY,
Lee KD and Chen MF: Significance of interleukin-6 signaling in the
resistance of pharyngeal cancer to irradiation and the epidermal
growth factor receptor inhibitor. Int J Radiat Oncol Biol Phys.
76:1214–1224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han Z, Feng J, Hong Z, Chen L, Li W, Liao
S, Wang X, Ji T, Wang S, Ma D, Chen G and Gao Q: Silencing of the
STAT3 signaling pathway reverses the inherent and induced
chemoresistance of human ovarian cancer cells. Biochem Biophys Res
Commun. 435:188–194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan HQ, Huang XB, Ke SZ, Jiang YN, Zhang
YH, Wang YN, Li J and Gao FG: Interleukin 6 augments lung cancer
chemotherapeutic resistance via ataxia-telangiectasia
mutated/NF-kappaB pathway activation. Cancer Sci. 105:1220–1227.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sobin LH, Witte Sobin LH and Wittekind CH:
TNM Classification of Malignant Tumors. 6th edition. Wiley-Liss;
New York, NY: 2002
|
|
22
|
Wahi PN, Cohen B, Luthra UK, et al:
Histological consideration. Histological Typing of Oral and
Orpharyngeal Tumors. Wahi PN, Cohen B, Luthra UK, et al: World
Health Organization; Geneva: pp. 15–19. 1977
|
|
23
|
Yamamoto E, Miyakawa A and Kohama G: Mode
of invasion and lymph node metastasis in squamous cell carcinoma of
the oral cavity. Head Neck Surg. 6:938–947. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shimosato Y, Oboshi S and Baba K:
Histological evaluation of effects of radiotherapy and chemotherapy
for carcinomas. Jpn J Clin Oncol. 1:19–35. 1971.
|
|
25
|
Riedel F, Zaiss I, Herzog D, Götte K, Naim
R and Hörmann K: Serum levels of interleukin-6 in patients with
primary head and neck squamous cell carcinoma. Anticancer Res.
25:2761–2765. 2005.PubMed/NCBI
|
|
26
|
Duffy SA, Taylor JM, Terrell JE, Islam M,
Li Y, Fowler KE, Wolf GT and Teknos TN: Interleukin-6 predicts
recurrence and survival among head and neck cancer patients.
Cancer. 113:750–757. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meyer F, Samson E, Douville P, Duchesne T,
Liu G and Bairati I: Serum prognostic markers in head and neck
cancer. Clin Cancer Res. 16:1008–1015. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mojtahedi Z, Khademi B, Hashemi SB, Abtahi
SM, Ghasemi MA, Fattahi MJ and Ghaderi A: Serum interleukin-6
concentration, but not interleukin-18, is associated with head and
neck squamous cell carcinoma progression. Pathol Oncol Res.
17:7–10. 2011. View Article : Google Scholar
|
|
29
|
Sato J, Ohuchi M, Abe K, Satoh T, Abe T,
Yamazaki Y, Satoh A, Notani K and Kitagawa Y: Correlation between
salivary interleukin-6 levels and early locoregional recurrence in
patients with oral squamous cell carcinoma: preliminary study. Head
Neck. 35:889–894. 2013. View Article : Google Scholar
|
|
30
|
Shinriki S, Jono H, Ueda M, Ota K, Ota T,
Sueyoshi T, Oike Y, Ibusuki M, Hiraki A, Nakayama H, Shinohara M
and Ando Y: Interleukin-6 signalling regulates vascular endothelial
growth factor-C synthesis and lymphangiogenesis in human oral
squamous cell carcinoma. J Pathol. 225:142–150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lane D, Matte I, Rancourt C and Piché A:
Prognostic significance of IL-6 and IL-8 ascites levels in ovarian
cancer patients. BMC Cancer. 11:2102011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen MF, Chen PT, Lu MS, Lin PY, Chen WC
and Lee KD: IL-6 expression predicts treatment response and outcome
in squamous cell carcinoma of the esophagus. Mol Cancer. 12:262013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hirano T, Nakajima K and Hibi M: Signaling
mechanisms through gp130: A model of the cytokine system. Cytokine
Growth Factor Rev. 8:241–252. 1997. View Article : Google Scholar
|
|
34
|
Chakravarti N, Myers JN and Aggarwal BB:
Targeting constitutive and interleukin-6-inducible signal
transducers and activators of transcription 3 pathway in head and
neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
Int J Cancer. 119:1268–1275. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Calò V, Migliavacca M, Bazan V, Macaluso
M, Buscemi M, Gebbia N and Russo A: STAT proteins: From normal
control of cellular events to tumorigenesis. J Cell Physiol.
197:157–168. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bromberg J and Darnell JE Jr: The role of
STATs in transcriptional control and their impact on cellular
function. Oncogene. 19:2468–2473. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hsu CP and Chung YC: Influence of
interleukin-6 on the invasiveness of human colorectal carcinoma.
Anticancer Res. 26:4607–4614. 2006.
|
|
38
|
Ara T and Declerck YA: Interleukin-6 in
bone metastasis and cancer progression. Eur J Cancer. 46:1223–1231.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jimi E, Furuta H, Matsuo K, Tominaga K,
Takahashi T and Nakanishi O: The cellular and molecular mechanisms
of bone invasion by oral squamous cell carcinoma. Oral Dis.
17:462–468. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sugimura K, Miyata H, Tanaka K, Hamano R,
Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori
M and Doki Y: Let-7 expression is a significant determinant of
response to chemotherapy through the regulation of IL-6/STAT3
pathway in esophageal squamous cell carcinoma. Clin Cancer Res.
18:5144–5153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ
and Li LZ: Autocrine production of interleukin-6 confers cisplatin
and paclitaxel resistance in ovarian cancer cells. Cancer Lett.
295:110–123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gilbert LA and Hemann MT: DNA
damage-mediated induction of a chemoresistant niche. Cell.
143:355–366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen CJ, Sung WW, Lin YM, Chen MK, Lee CH,
Lee H, Yeh KT and Ko JL: Gender difference in the prognostic role
of interleukin 6 in oral squamous cell carcinoma. PLoS One.
7:e501042012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang YF, Chang SY, Tai SK, Li WY and Wang
LS: Clinical significance of interleukin-6 and interleukin-6
receptor expressions in oral squamous cell carcinoma. Head Neck.
24:850–858. 2002. View Article : Google Scholar : PubMed/NCBI
|
